Cargando…
Immunotherapeutic interventions of Triple Negative Breast Cancer
Triple Negative Breast Cancer (TNBC) is a highly heterogeneous subtype of breast cancer that lacks the expression of oestrogen receptors, progesterone receptors and human epidermal growth factor receptor 2. Although TNBC is sensitive to chemotherapy, the overall outcomes of TNBC are worse than for o...
Autores principales: | Li, Zehuan, Qiu, Yiran, Lu, Weiqi, Jiang, Ying, Wang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977468/ https://www.ncbi.nlm.nih.gov/pubmed/29848327 http://dx.doi.org/10.1186/s12967-018-1514-7 |
Ejemplares similares
-
Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives
por: Oualla, Karima, et al.
Publicado: (2020) -
Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential
por: Das, Kaushik, et al.
Publicado: (2023) -
Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects
por: Khadela, Avinash, et al.
Publicado: (2022) -
Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023) -
Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer
por: Chen, Xuanzhao, et al.
Publicado: (2023)